Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Transparency
Large Canadian Drug Companies Begin Voluntarily Disclosing Information
Ten well-known drug companies in Canada have started to voluntarily disclose how much money they pay to physicians, hospitals, and…
Ontario Enters the Transparency Spotlight
Over three years ago, the Toronto Star filed a freedom of information (FIPPA) request with the Health Ministry in Ontario, Canada,…
CMS Releases 2016 Open Payments Data
2016 Open Payments Data was released on Friday, June 30, 2017. In 2016, the total dollar amount of payments totaled $8.18 billion.…
Chicago Releases Pharmaceutical Representative Disclosure Log Draft
The City of Chicago recently released a draft of the disclosure log pharmaceutical representatives will be expected to use to keep…
California Gift Ban Bill to be Heard Tomorrow
On Tuesday, June 27, 2017, California Senate Bill 790 will be heard in the Assembly Committee on Health, with limited testimony…
Amgen Biosimilar Report Released
For the past three years, Amgen has faithfully released an annual “Trends in Biosimilars Report.” This year’s report highlights…
What Does the Nevada Law Mean for Pharma?
We have written several articles on the Nevada bill that requires patient advocacy organizations to report all payments they…
Nevada Bill Requiring Patient Advocacy Transparency – Governor Expected to…
After being vetoed the week before the Nevada State Legislature passed a bill to combat drug prices but also requires patient…
Maine and Missouri Propose Legislation Restricting Industry and Physician…
As we are all aware, many states have started to take notice of the heat industry is under for its interactions with physicians.…
Nevada, Round Two – Price and Non Profit Transparency Bill Added…
Some of our loyal readers may remember an article we ran last week about the Nevada state legislature passing one of the country’s…